Avion Pharmaceuticals, an Alora Pharmaceuticals subsidiary company focused on advancing treatment for Parkinson's disease, is proud to announce the findings from a recently published study examining ...

Advanced Parkinson's disease patients in Calgary have had access since 2024 to a treatment called Vyalev, which an Edmonton ...

From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

A new study suggests that receiving text-based 'nudges' could help remind patients to refill their prescriptions, which may also help to reduce readmission rates.

Researchers decipher the function of an ion channel involved in cellular degradation processes and create new possibilities for Parkinson's ...

Lysosomes are the recycling centers of human cells. Larger molecules are broken down inside the membrane-enclosed vesicles. Malfunctions can lead to neurodegenerative diseases such as Parkinson's.

Researchers decipher the function of an ion channel involved in cellular degradation processes and create new possibilities for Parkinson’s therapies.

Explore Duopa, an advanced Parkinson's disease treatment that uses carbidopa-levodopa gel infusion for steady dopamine levels, reducing motor fluctuations effectively.

Viking Therapeutics and Aspen Neuroscience have both stepped up their commercialization planning, each tapping leaders with resumes spanning the likes of Amgen, Eli Lilly, Merck and GSK to oversee ...